TUBERCULIN PURIFIED PROTEIN DERIVATIVE

TUBERCULIN PURIFIED PROTEIN DERIVATIVE was reported 1886 times

TUBERCULIN PURIFIED PROTEIN DERIVATIVE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ELECTROMYOGRAM NORMAL 1 0.5000
1 TUBERCULIN TEST NEGATIVE 3 0.3333
2 VACCINATION SITE NECROSIS 1 0.3333
3 VACCINATION SITE IRRITATION 1 0.2000
4 VACCINATION SITE INDURATION 6 0.1765
5 VACCINATION SITE PRURITUS 8 0.1569
6 VACCINATION SITE RASH 6 0.1429
7 VACCINATION SITE INFLAMMATION 8 0.1404
8 EXTENSIVE SWELLING OF VACCINATED LIMB 3 0.1364
9 VACCINATION SITE VESICLES 3 0.1364
10 GASTROENTERITIS NORWALK VIRUS 2 0.1053
11 MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST NEGATIVE 1 0.1000
12 VACCINATION SITE LYMPHADENOPATHY 1 0.1000
13 BLOOD CADMIUM INCREASED 1 0.0909
14 COW POX 1 0.0909
15 VACCINATION SITE CELLULITIS 2 0.0769
16 VACCINATION SITE ERYTHEMA 14 0.0648
17 VACCINATION SITE INFECTION 1 0.0625
18 TUBERCULIN TEST FALSE POSITIVE 7 0.0526
19 TUBERCULOSIS SKIN TEST POSITIVE 4 0.0494
20 MANUFACTURING PRODUCT STORAGE ISSUE 4 0.0476
21 BLADDER NECK OPERATION 1 0.0455
22 OVARIAN INFECTION 1 0.0435
23 VACCINATION SITE BRUISING 1 0.0417
24 POOR QUALITY PRODUCT ADMINISTERED 432 0.0409
25 VACCINATION SITE WARMTH 2 0.0339
26 VACCINATION SITE REACTION 4 0.0310
27 VACCINATION SITE OEDEMA 1 0.0303
28 POLYMORPHIC ERUPTION OF PREGNANCY 1 0.0286
29 OILY SKIN 1 0.0256
30 FALSE POSITIVE TUBERCULOSIS TEST 7 0.0222
31 URTICARIA LOCALISED 1 0.0213
32 INTRANASAL PARAESTHESIA 1 0.0200
33 SYNCOPE VASOVAGAL 8 0.0160
34 FACTOR VII DEFICIENCY 1 0.0149
35 WRONG PRODUCT ADMINISTERED 98 0.0145
36 HISTAMINE ABNORMAL 1 0.0143
37 EXPOSURE VIA EYE CONTACT 6 0.0143
38 ERYTHEMA INDURATUM 2 0.0141
39 RENAL SCAN ABNORMAL 1 0.0141
40 VACCINATION SITE PAIN 7 0.0122
41 VACCINATION SITE SWELLING 2 0.0116
42 LYMPHOCYTE COUNT 1 0.0114
43 PARAESTHESIA MUCOSAL 1 0.0108
44 DIALYSIS HYPOTENSION 1 0.0101
45 ALLERGY TO VACCINE 3 0.0097
46 RASH SCALY 1 0.0094
47 UNRESPONSIVE TO VERBAL STIMULI 2 0.0093
48 TRACHEAL INFLAMMATION 1 0.0092
49 REGURGITATION OF FOOD 1 0.0091
50 TUBERCULIN TEST POSITIVE 20 0.0079
51 ARTERIOVENOUS FISTULA SITE INFECTION 1 0.0074
52 INCISION SITE OEDEMA 1 0.0072
53 INJECTED LIMB MOBILITY DECREASED 1 0.0070
54 BASAL GANGLIA STROKE 1 0.0069
55 INJECTION SITE DERMATITIS 1 0.0069
56 LOCAL REACTION 5 0.0067
57 OSTEOPOROSIS POSTMENOPAUSAL 1 0.0067
58 BRACHIAL PLEXUS INJURY 1 0.0062
59 INDURATION 11 0.0062
60 ACUTE CARDIAC EVENT 1 0.0058
61 ARTERIOVENOUS FISTULA OCCLUSION 1 0.0057
62 EYE ROLLING 4 0.0056
63 APPLICATION SITE HAEMATOMA 1 0.0055
64 SKIN INFLAMMATION 1 0.0051
65 SHOULDER DEFORMITY 1 0.0051
66 HEPATITIS A ANTIBODY POSITIVE 1 0.0051
67 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 86 0.0050
68 URTICARIA GENERALISED 3 0.0046
69 TESTICULAR MASS 1 0.0046
70 BRACHIAL PLEXOPATHY 1 0.0045
71 VOCAL CORD PARESIS 1 0.0043
72 INJECTION SITE VESICLES 26 0.0043
73 INJECTION SITE NERVE DAMAGE 1 0.0042
74 EXPIRED PRODUCT ADMINISTERED 139 0.0042
75 INJECTION SITE OEDEMA 7 0.0041
76 LATEX ALLERGY 1 0.0041
77 INJECTION SITE STREAKING 1 0.0040
78 ERYTHEMA INFECTIOSUM 1 0.0039
79 CORNEAL THINNING 1 0.0039
80 PRODUCT STORAGE ERROR 322 0.0037
81 AGONAL RESPIRATION 1 0.0035
82 SUBCUTANEOUS NODULE 1 0.0035
83 DOCUMENTED HYPERSENSITIVITY TO ADMINISTERED DRUG 1 0.0034
84 INJECTION SITE INFLAMMATION 17 0.0034
85 BLOOD CREATINE DECREASED 1 0.0033
86 WRONG DRUG ADMINISTERED 29 0.0033
87 INJECTION SITE INDURATION 42 0.0032
88 CORNEAL INFILTRATES 1 0.0032
89 LACUNAR STROKE 1 0.0031
90 LOSS OF PROPRIOCEPTION 1 0.0031
91 PARAKERATOSIS 1 0.0031
92 TONIC CLONIC MOVEMENTS 4 0.0031
93 ACANTHOSIS 1 0.0030
94 GAIT SPASTIC 1 0.0029
95 BASAL GANGLIA INFARCTION 1 0.0029
96 ANION GAP DECREASED 1 0.0029
97 BURNING SENSATION MUCOSAL 1 0.0028
98 LYMPHOID TISSUE HYPERPLASIA 1 0.0028
99 BRAIN CONTUSION 2 0.0027
100 SUSPECTED PRODUCT QUALITY ISSUE 5 0.0027
101 POOR QUALITY DRUG ADMINISTERED 17 0.0026
102 INJECTION SITE BURNING 2 0.0026
103 CAT SCRATCH DISEASE 1 0.0025
104 LACK OF SPONTANEOUS SPEECH 1 0.0023
105 PRODUCT WITH QUALITY ISSUE ADMINISTERED 1 0.0022
106 ENLARGED UVULA 1 0.0022
107 DRUG DETOXIFICATION 2 0.0022
108 ARTERIOVENOUS MALFORMATION 2 0.0022
109 SEXUALLY INAPPROPRIATE BEHAVIOUR 1 0.0021
110 SKIN TEST POSITIVE 2 0.0021
111 PRODUCT TEMPERATURE EXCURSION ISSUE 11 0.0021
112 STATUS ASTHMATICUS 1 0.0021
113 TONIC CONVULSION 3 0.0021
114 WOUND NECROSIS 1 0.0021
115 AXILLARY PAIN 3 0.0020
116 PULSE PRESSURE DECREASED 1 0.0020
117 KELOID SCAR 1 0.0019
118 POSTURING 1 0.0019
119 TRACHEAL DISORDER 1 0.0019
120 NO REACTION ON PREVIOUS EXPOSURE TO DRUG 1 0.0019
121 SKIN WARM 11 0.0019
122 ASPARTATE AMINOTRANSFERASE DECREASED 1 0.0019
123 TYPE III IMMUNE COMPLEX MEDIATED REACTION 1 0.0018
124 ORAL PRURITUS 4 0.0017
125 CORNEAL EPITHELIUM DEFECT 1 0.0017
126 TRANSAMINASES ABNORMAL 1 0.0017
127 OCCUPATIONAL EXPOSURE TO PRODUCT 11 0.0017
128 ARTERIOVENOUS FISTULA SITE COMPLICATION 1 0.0017
129 UNINTENTIONAL USE FOR UNAPPROVED INDICATION 1 0.0017
130 LYMPHADENITIS 4 0.0017
131 TOOTH EROSION 2 0.0016
132 CERVICOBRACHIAL SYNDROME 1 0.0016
133 CHEST X-RAY ABNORMAL 5 0.0016
134 INJECTION SITE CELLULITIS 3 0.0016
135 LYMPH NODE PAIN 3 0.0016
136 PERNICIOUS ANAEMIA 1 0.0016
137 SENSATION OF HEAVINESS 6 0.0015
138 BODY MASS INDEX INCREASED 2 0.0015
139 HEAD AND NECK CANCER 1 0.0015
140 INJECTION SITE NECROSIS 3 0.0015
141 SOFT TISSUE NECROSIS 1 0.0015
142 TONGUE PARALYSIS 1 0.0014
143 ANTERIOR CHAMBER CELL 1 0.0014
144 PROTEUS INFECTION 1 0.0014
145 ESCHAR 1 0.0014
146 LYMPH NODE TUBERCULOSIS 1 0.0013
147 HYPOAESTHESIA FACIAL 2 0.0013
148 INJECTION SITE PARAESTHESIA 2 0.0013
149 LABORATORY TEST INTERFERENCE 1 0.0013
150 INJECTION SITE WARMTH 26 0.0013
151 THROAT TIGHTNESS 34 0.0013
152 SKIN BACTERIAL INFECTION 1 0.0012
153 EXCESSIVE GRANULATION TISSUE 1 0.0012
154 GUILLAIN-BARRE SYNDROME 6 0.0012
155 REACTION TO PRESERVATIVES 1 0.0012
156 ANAPHYLACTOID REACTION 5 0.0012
157 CULTURE POSITIVE 1 0.0012
158 LIP PRURITUS 1 0.0012
159 TONGUE PRURITUS 1 0.0012
160 INJECTION SITE DISCOLOURATION 14 0.0011
161 COLOUR BLINDNESS 1 0.0011
162 LOCALISED OEDEMA 5 0.0011
163 MENINGIOMA BENIGN 1 0.0011
164 PNEUMONIA CRYPTOCOCCAL 1 0.0011
165 BLOOD ALKALINE PHOSPHATASE DECREASED 1 0.0011
166 PHARYNGEAL OEDEMA 16 0.0010
167 PARAESTHESIA ORAL 15 0.0010
168 INJECTION SITE SCAB 1 0.0010
169 SHOULDER PAIN 1 0.0010
170 SKIN OEDEMA 1 0.0010
171 LYMPHOCYTIC INFILTRATION 1 0.0010
172 FALSE POSITIVE INVESTIGATION RESULT 1 0.0010
173 THROMBOPHLEBITIS SUPERFICIAL 3 0.0010
174 EAR HAEMORRHAGE 2 0.0010
175 SUSPECTED PRODUCT CONTAMINATION 1 0.0010
176 ALVEOLITIS ALLERGIC 1 0.0010
177 PERTUSSIS 1 0.0010
178 LIVEDO RETICULARIS 2 0.0010
179 CARPAL TUNNEL DECOMPRESSION 1 0.0009
180 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 1 0.0009
181 NEUROMYOPATHY 1 0.0009
182 INTRACRANIAL VENOUS SINUS THROMBOSIS 1 0.0009
183 IMMEDIATE POST-INJECTION REACTION 1 0.0009
184 NAIL GROWTH ABNORMAL 1 0.0009
185 OPEN WOUND 1 0.0009
186 PALLOR 24 0.0009
187 ADMINISTRATION SITE PAIN 1 0.0009
188 INJECTION SITE IRRITATION 11 0.0009
189 NEPHROGENIC ANAEMIA 4 0.0009
190 ALLODYNIA 1 0.0009
191 MULTIMORBIDITY 1 0.0008
192 CHRONIC RESPIRATORY FAILURE 1 0.0008
193 STARING 2 0.0008
194 PHARYNGEAL INFLAMMATION 1 0.0008
195 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 5 0.0008
196 BLOOD UREA DECREASED 1 0.0008
197 INJECTION SITE ABSCESS 2 0.0008
198 HYPERPARATHYROIDISM SECONDARY 2 0.0008
199 INJECTION SITE PRURITUS 53 0.0008
200 PRESYNCOPE 19 0.0008
201 ANGIONEUROTIC OEDEMA 2 0.0007
202 AREFLEXIA 2 0.0007
203 LARYNGOSPASM 2 0.0007
204 CARBON DIOXIDE INCREASED 1 0.0007
205 INJECTION SITE ERYTHEMA 91 0.0007
206 ACCIDENTAL EXPOSURE 3 0.0007
207 INCISIONAL HERNIA 1 0.0007
208 SERUM SICKNESS 2 0.0007
209 INJECTION SITE RASH 22 0.0007
210 PRURITUS GENERALISED 15 0.0007
211 INJECTION SITE REACTION 47 0.0007
212 STRIDOR 2 0.0007
213 COMPLEX REGIONAL PAIN SYNDROME 1 0.0007
214 INTERCEPTED DRUG DISPENSING ERROR 1 0.0007
215 INCORRECT ROUTE OF DRUG ADMINISTRATION 24 0.0007
216 INJECTION SITE PAPULE 3 0.0007
217 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 12 0.0007
218 PULMONARY FUNCTION TEST ABNORMAL 1 0.0006
219 INTERMITTENT CLAUDICATION 1 0.0006
220 SKULL FRACTURE 1 0.0006
221 SWOLLEN TONGUE 19 0.0006
222 PAPILLOMA VIRAL INFECTION 1 0.0006
223 VENA CAVA THROMBOSIS 1 0.0006
224 VACCINATION FAILURE 1 0.0006
225 SPINAL DEFORMITY 1 0.0006
226 SEIZURE LIKE PHENOMENA 1 0.0006
227 PHLEBITIS 3 0.0006
228 CHOREA 1 0.0006
229 ACUTE SINUSITIS 1 0.0006
230 RASH GENERALISED 15 0.0006
231 HYPOPNOEA 2 0.0006
232 TENDERNESS 6 0.0006
233 MENINGITIS CRYPTOCOCCAL 1 0.0006
234 EAR PRURITUS 2 0.0006
235 FOOD INTERACTION 1 0.0006
236 PHARYNGOLARYNGEAL PAIN 3 0.0006
237 MUSCLE CRAMP 1 0.0006
238 VOCAL CORD PARALYSIS 1 0.0006
239 ESSENTIAL HYPERTENSION 1 0.0005
240 OESOPHAGEAL SPASM 1 0.0005
241 GRAND MAL CONVULSION 5 0.0005
242 DYSENTERY 1 0.0005
243 AURA 1 0.0005
244 LIVING IN RESIDENTIAL INSTITUTION 1 0.0005
245 SACROILIITIS 1 0.0005
246 INJECTION SITE URTICARIA 13 0.0005
247 ANAPHYLACTIC REACTION 29 0.0005
248 CONVERSION DISORDER 1 0.0005
249 NASAL SEPTUM DEVIATION 1 0.0005
250 DERMATITIS PSORIASIFORM 1 0.0005
251 SELF-MEDICATION 2 0.0005
252 POLYCYTHAEMIA 1 0.0005
253 ATRIAL THROMBOSIS 1 0.0005
254 MICROCYTIC ANAEMIA 1 0.0005
255 LATENT TUBERCULOSIS 1 0.0005
256 ERYTHEMA 98 0.0005
257 DILATATION VENTRICULAR 1 0.0005
258 NEUROGENIC BLADDER 1 0.0005
259 PHARYNGEAL ERYTHEMA 1 0.0005
260 FACIAL PALSY 1 0.0005
261 MONOPLEGIA 2 0.0005
262 REACTION TO DRUG EXCIPIENTS 1 0.0005
263 CORNEAL DISORDER 1 0.0005
264 PURPURA 4 0.0005
265 RASH PAPULAR 10 0.0004
266 INFECTIOUS MONONUCLEOSIS 1 0.0004
267 APPLICATION SITE URTICARIA 1 0.0004
268 PERIARTHRITIS 1 0.0004
269 WHEEZING 26 0.0004
270 RESPIRATION ABNORMAL 3 0.0004
271 DROOLING 3 0.0004
272 EYELID DISORDER 1 0.0004
273 FLAT AFFECT 1 0.0004
274 ESCHERICHIA BACTERAEMIA 1 0.0004
275 MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE 1 0.0004
276 PRE-ECLAMPSIA 2 0.0004
277 EOSINOPHIL COUNT DECREASED 1 0.0004
278 VARICELLA 1 0.0004
279 PULSE ABNORMAL 1 0.0004
280 RASH VESICULAR 2 0.0004
281 PRODUCT PACKAGING CONFUSION 1 0.0004
282 URTICARIA 69 0.0004
283 HYPERNATRAEMIA 2 0.0004
284 VASODILATATION 1 0.0004
285 EXCORIATION 1 0.0004
286 PRODUCT CONTAMINATION PHYSICAL 1 0.0004
287 UNRESPONSIVE TO STIMULI 10 0.0004
288 CYANOSIS 6 0.0004
289 THROAT IRRITATION 17 0.0004
290 NYSTAGMUS 2 0.0004
291 RASH ERYTHEMATOUS 18 0.0004
292 SYNCOPE 37 0.0004
293 RASH PRURITIC 20 0.0004
294 HYPERAESTHESIA 3 0.0004
295 NONSPECIFIC REACTION 2 0.0004
296 DEAFNESS UNILATERAL 2 0.0004
297 TENOSYNOVITIS 1 0.0004
298 PROCTITIS 1 0.0004
299 SENSATION OF FOREIGN BODY 3 0.0004
300 PREMATURE LABOUR 2 0.0004
301 NECK MASS 1 0.0004
302 INJECTION SITE SWELLING 27 0.0004
303 JOINT LOCK 1 0.0004
304 GENERALISED ERYTHEMA 2 0.0004
305 DYSPNOEA AT REST 1 0.0003
306 ESCHERICHIA SEPSIS 1 0.0003
307 RASH MACULAR 12 0.0003
308 FEELING HOT 21 0.0003
309 AUTONOMIC NERVOUS SYSTEM IMBALANCE 1 0.0003
310 WRONG PATIENT RECEIVED PRODUCT 1 0.0003
311 NECK INJURY 1 0.0003
312 CREPITATIONS 1 0.0003
313 HYPOAESTHESIA ORAL 5 0.0003
314 LOSS OF EMPLOYMENT 1 0.0003
315 LIP SWELLING 11 0.0003
316 EMERGENCY CARE 1 0.0003
317 EMBOLISM VENOUS 1 0.0003
318 DYSAESTHESIA 1 0.0003
319 DIASTOLIC DYSFUNCTION 1 0.0003
320 CHEST DISCOMFORT 33 0.0003
321 ERYTHEMA MULTIFORME 3 0.0003
322 BLOOD BLISTER 1 0.0003
323 INJECTION SITE HYPERSENSITIVITY 1 0.0003
324 BLADDER PAIN 1 0.0003
325 HYPERSENSITIVITY 58 0.0003
326 VENTRICULAR HYPOKINESIA 1 0.0003
327 LYMPHADENOPATHY 11 0.0003
328 ATELECTASIS 3 0.0003
329 LOOSE TOOTH 1 0.0003
330 POSTURE ABNORMAL 1 0.0003
331 PHARYNGEAL SWELLING 3 0.0003
332 OEDEMA MOUTH 1 0.0003
333 THROMBOSIS IN DEVICE 1 0.0003
334 INJECTION SITE INFECTION 1 0.0003
335 NEAR DEATH EXPERIENCE 1 0.0003
336 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 1 0.0003
337 CYTOLYTIC HEPATITIS 1 0.0003
338 LYME DISEASE 1 0.0003
339 CELLULITIS 15 0.0003
340 EYE MOVEMENT DISORDER 2 0.0003
341 SWELLING FACE 19 0.0003
342 ECCHYMOSIS 2 0.0003
343 PUSTULAR PSORIASIS 1 0.0003
344 INFLAMMATION 15 0.0003
345 VIITH NERVE PARALYSIS 1 0.0003
346 ENCEPHALITIS 2 0.0003
347 GRANULOMA 1 0.0003
348 PETECHIAE 3 0.0003
349 FEELING COLD 8 0.0003
350 LOCAL SWELLING 5 0.0003
351 MASS 4 0.0003
352 MUSCLE CONTRACTIONS INVOLUNTARY 1 0.0003
353 HANGOVER 1 0.0003
354 TYPE I HYPERSENSITIVITY 1 0.0003
355 COLD SWEAT 5 0.0003
356 FACIAL PARESIS 1 0.0003
357 HAEMORRHAGE SUBCUTANEOUS 1 0.0003
358 BREAST PAIN 3 0.0003
359 INTERCEPTED PRODUCT STORAGE ERROR 1 0.0003
360 LETHARGY 16 0.0003
361 LIVER TRANSPLANT 1 0.0003
362 CUTANEOUS VASCULITIS 1 0.0003
363 THROMBOCYTOSIS 1 0.0003
364 EXTRA DOSE ADMINISTERED 11 0.0003
365 PHARMACEUTICAL PRODUCT COMPLAINT 7 0.0003
366 HYPERACUSIS 1 0.0003
367 CHRONIC SINUSITIS 1 0.0003
368 PROTEIN TOTAL DECREASED 1 0.0003
369 PRURITUS 102 0.0003
370 PAROSMIA 2 0.0003
371 PARANASAL SINUS DISCOMFORT 1 0.0003
372 CONVULSION 15 0.0003
373 CONJUNCTIVAL HAEMORRHAGE 1 0.0003
374 THYROID MASS 1 0.0003
375 WOUND SECRETION 1 0.0003
376 RESPIRATORY ACIDOSIS 1 0.0003
377 BLOOD ALBUMIN DECREASED 2 0.0003
378 MEDICATION ERROR 14 0.0003
379 MYOCLONUS 3 0.0003
380 MUSCLE RIGIDITY 3 0.0003
381 SENSORY DISTURBANCE 4 0.0002
382 MUSCLE HAEMORRHAGE 1 0.0002
383 TRIGEMINAL NEURALGIA 1 0.0002
384 SENSORY LOSS 2 0.0002
385 MATERNAL EXPOSURE DURING BREAST FEEDING 1 0.0002
386 ACCIDENTAL OVERDOSE 9 0.0002
387 APPLICATION SITE EXFOLIATION 1 0.0002
388 RED CELL DISTRIBUTION WIDTH INCREASED 1 0.0002
389 FACE OEDEMA 4 0.0002
390 SKIN PLAQUE 2 0.0002
391 LIP OEDEMA 1 0.0002
392 DRUG EXPOSURE DURING PREGNANCY 8 0.0002
393 PURULENT DISCHARGE 1 0.0002
394 LEFT VENTRICULAR HYPERTROPHY 1 0.0002
395 TEARFULNESS 1 0.0002
396 BLISTER 13 0.0002
397 STAPHYLOCOCCAL BACTERAEMIA 1 0.0002
398 RESPIRATORY RATE INCREASED 2 0.0002
399 RASH MACULO-PAPULAR 5 0.0002
400 RHINITIS ALLERGIC 1 0.0002
401 SWELLING 21 0.0002
402 PARAESTHESIA 35 0.0002
403 OROPHARYNGEAL DISCOMFORT 2 0.0002
404 DYSPHAGIA 21 0.0002
405 TACHYPNOEA 3 0.0002
406 END STAGE RENAL DISEASE 4 0.0002
407 BUNDLE BRANCH BLOCK RIGHT 1 0.0002
408 FLUSHING 22 0.0002
409 BURNING SENSATION 15 0.0002
410 SKIN REACTION 3 0.0002
411 DIALYSIS 3 0.0002
412 BLOOD PRESSURE DECREASED 14 0.0002
413 SARCOIDOSIS 1 0.0002
414 VIRAL UPPER RESPIRATORY TRACT INFECTION 1 0.0002
415 GESTATIONAL DIABETES 1 0.0002
416 SUBCUTANEOUS ABSCESS 1 0.0002
417 HYPOAESTHESIA 31 0.0002
418 INCORRECT DOSAGE ADMINISTERED 1 0.0002
419 EXPIRED DRUG ADMINISTERED 1 0.0002
420 ABDOMINAL TENDERNESS 1 0.0002
421 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 1 0.0002
422 BODY TEMPERATURE INCREASED 4 0.0002
423 PETIT MAL EPILEPSY 1 0.0002
424 EAR DISCOMFORT 2 0.0002
425 INCREASED UPPER AIRWAY SECRETION 1 0.0002
426 LIMB DISCOMFORT 6 0.0002
427 SKIN NECROSIS 1 0.0002
428 PERIORBITAL OEDEMA 1 0.0002
429 TONSILLITIS 1 0.0002
430 CATATONIA 1 0.0002
431 SCRATCH 2 0.0002
432 EYE SWELLING 7 0.0002
433 DYSPHONIA 11 0.0002
434 INJECTION SITE DISCHARGE 1 0.0002
435 SKIN LESION 5 0.0002
436 HYPERKERATOSIS 1 0.0002
437 DENTAL CARIES 2 0.0002
438 HYPERTENSIVE CRISIS 2 0.0002
439 STREPTOCOCCAL INFECTION 1 0.0002
440 LOSS OF CONSCIOUSNESS 23 0.0002
441 MALNUTRITION 2 0.0002
442 ANGIOPATHY 1 0.0002
443 UPPER GASTROINTESTINAL HAEMORRHAGE 3 0.0002
444 SKIN INFECTION 2 0.0002
445 MULTIPLE USE OF SINGLE-USE PRODUCT 1 0.0002
446 BLOOD CALCIUM DECREASED 2 0.0002
447 HEMIPARESIS 3 0.0002
448 COLECTOMY 1 0.0002
449 PERONEAL NERVE PALSY 1 0.0002
450 DYSGEUSIA 13 0.0002
451 CARDIAC VALVE DISEASE 1 0.0002
452 EXERCISE TOLERANCE DECREASED 1 0.0002
453 HYPERVENTILATION 1 0.0002
454 OEDEMA PERIPHERAL 21 0.0002
455 DYSKINESIA 7 0.0002
456 EYELID OEDEMA 2 0.0002
457 OVERDOSE 37 0.0002
458 HEART RATE DECREASED 6 0.0002
459 FEELING OF BODY TEMPERATURE CHANGE 1 0.0002
460 CHILLS 20 0.0002
461 DYSPNOEA 96 0.0002
462 PROTHROMBIN TIME PROLONGED 1 0.0002
463 RESPIRATORY DISORDER 5 0.0002
464 MUSCLE SPASTICITY 2 0.0002
465 SCOLIOSIS 1 0.0002
466 MIDDLE INSOMNIA 3 0.0002
467 INJECTION SITE PAIN 49 0.0002
468 DERMATITIS ALLERGIC 2 0.0002
469 PHOTOPSIA 1 0.0002
470 HYPERHIDROSIS 20 0.0002
471 HEPATITIS ACUTE 1 0.0002
472 PALPITATIONS 18 0.0002
473 PLATELET COUNT INCREASED 2 0.0002
474 NODULE 2 0.0002
475 SKIN IRRITATION 7 0.0002
476 PULMONARY CONGESTION 2 0.0002
477 APPETITE DISORDER 1 0.0002
478 BRADYCARDIA 8 0.0002
479 MENINGITIS 1 0.0001
480 LEFT VENTRICULAR DYSFUNCTION 1 0.0001
481 JOINT RANGE OF MOTION DECREASED 2 0.0001
482 RASH 65 0.0001
483 PRODUCT LABEL ISSUE 1 0.0001
484 PERIPHERAL COLDNESS 2 0.0001
485 RESPIRATORY DISTRESS 4 0.0001
486 LYMPHOEDEMA 1 0.0001
487 INCORRECT DOSE ADMINISTERED 33 0.0001
488 FORMICATION 1 0.0001
489 APHONIA 2 0.0001
490 DUODENAL ULCER 1 0.0001
491 HEART RATE INCREASED 14 0.0001
492 THERMAL BURN 1 0.0001
493 FEAR OF INJECTION 1 0.0001
494 BRONCHOSPASM 2 0.0001
495 TONGUE DISORDER 1 0.0001
496 INJECTION SITE HAEMATOMA 2 0.0001
497 FLUID OVERLOAD 2 0.0001
498 GASTROENTERITIS 2 0.0001
499 ORAL DISORDER 1 0.0001
500 MELAENA 3 0.0001
501 ANGIOEDEMA 6 0.0001
502 BLINDNESS TRANSIENT 1 0.0001
503 BLOOD PRESSURE DIASTOLIC DECREASED 1 0.0001
504 HYDRONEPHROSIS 1 0.0001
505 PYREXIA 46 0.0001
506 AORTIC ANEURYSM 1 0.0001
507 ACIDOSIS 1 0.0001
508 DIZZINESS 65 0.0001
509 MUSCLE TWITCHING 3 0.0001
510 DEVICE RELATED INFECTION 2 0.0001
511 FOOD ALLERGY 1 0.0001
512 ATRIOVENTRICULAR BLOCK 1 0.0001
513 PULMONARY HAEMORRHAGE 1 0.0001
514 HEAD INJURY 4 0.0001
515 RENAL CYST 1 0.0001
516 RESPIRATORY TRACT CONGESTION 2 0.0001
517 ULCER 2 0.0001
518 ATRIAL FLUTTER 1 0.0001
519 BLOOD PRESSURE FLUCTUATION 3 0.0001
520 ABORTION SPONTANEOUS 5 0.0001
521 MUSCLE TIGHTNESS 2 0.0001
522 BLOOD POTASSIUM INCREASED 2 0.0001
523 STAPHYLOCOCCAL INFECTION 4 0.0001
524 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 1 0.0001
525 ATRIAL SEPTAL DEFECT 1 0.0001
526 NASAL CONGESTION 7 0.0001
527 PAIN IN EXTREMITY 35 0.0001
528 CANDIDA INFECTION 2 0.0001
529 FACIAL PARALYSIS 1 0.0001
530 SCAR 2 0.0001
531 ANAPHYLACTIC SHOCK 3 0.0001
532 BLOOD MAGNESIUM DECREASED 1 0.0001
533 EXPOSURE VIA SKIN CONTACT 3 0.0001
534 SKIN SWELLING 1 0.0001
535 TREMOR 19 0.0001
536 MUSCULAR WEAKNESS 13 0.0001
537 SPINAL OSTEOARTHRITIS 1 0.0001
538 TUMOUR LYSIS SYNDROME 1 0.0001
539 GRIP STRENGTH DECREASED 1 0.0001
540 LUNG INFILTRATION 1 0.0001
541 LYMPHOCYTE COUNT DECREASED 2 0.0001
542 GASTROINTESTINAL INFECTION 1 0.0001
543 MYOSITIS 1 0.0001
544 ANAL INCONTINENCE 1 0.0001
545 LEUKOCYTOSIS 2 0.0001
546 PNEUMONIA BACTERIAL 1 0.0001
547 BRAIN NEOPLASM 1 0.0001
548 SKIN DISCOLOURATION 5 0.0001
549 BLOOD THYROID STIMULATING HORMONE INCREASED 1 0.0001
550 CHEST PAIN 20 0.0001
551 CONJUNCTIVITIS 2 0.0001
552 NEPHROPATHY 1 0.0001
553 PHOTOPHOBIA 2 0.0001
554 LACERATION 1 0.0001
555 OCULAR HYPERAEMIA 5 0.0001
556 POST PROCEDURAL COMPLICATION 2 0.0001
557 DIZZINESS POSTURAL 1 0.0001
558 VITAMIN D DEFICIENCY 1 0.0001
559 RENAL TUBULAR NECROSIS 1 0.0001
560 DECREASED IMMUNE RESPONSIVENESS 1 0.0001
561 HEPATOMEGALY 1 0.0001
562 BODY TEMPERATURE DECREASED 1 0.0001
563 URINARY INCONTINENCE 3 0.0001
564 ACTIVITIES OF DAILY LIVING IMPAIRED 2 0.0001
565 HAEMATOCRIT DECREASED 2 0.0001
566 HYPOTONIA 1 0.0001
567 PRODUCT ADMINISTRATION ERROR 2 0.0001
568 SUBARACHNOID HAEMORRHAGE 1 0.0001
569 NEUTROPHIL COUNT DECREASED 4 0.0001
570 NEUTROPHIL COUNT INCREASED 1 0.0001
571 OROPHARYNGEAL PAIN 9 0.0001
572 TEMPERATURE INTOLERANCE 1 0.0001
573 HYPERBILIRUBINAEMIA 1 0.0001
574 ASTHENIA 36 0.0001
575 GASTROINTESTINAL HAEMORRHAGE 8 0.0001
576 WEIGHT FLUCTUATION 1 0.0001
577 SPEECH DISORDER 5 0.0001
578 INJECTION SITE DISCOMFORT 1 0.0001
579 DRUG ADMINISTERED AT INAPPROPRIATE SITE 1 0.0001
580 INCONTINENCE 1 0.0001
581 CLOSTRIDIUM DIFFICILE COLITIS 1 0.0001
582 COUGH 26 0.0001
583 ALTERED STATE OF CONSCIOUSNESS 2 0.0001
584 BIPOLAR DISORDER 1 0.0001
585 BACK INJURY 1 0.0001
586 BLOOD PRESSURE INCREASED 14 0.0001
587 ASPIRATION 1 0.0001
588 INJECTION SITE NODULE 1 0.0001
589 STEVENS-JOHNSON SYNDROME 2 0.0001
590 NERVE INJURY 1 0.0001
591 OBSTRUCTIVE AIRWAYS DISORDER 1 0.0001
592 NAUSEA 71 0.0001
593 EYE PRURITUS 3 0.0001
594 SNEEZING 2 0.0001
595 STATUS EPILEPTICUS 1 0.0001
596 IMPAIRED DRIVING ABILITY 1 0.0001
597 SCAB 1 0.0001
598 INJECTION SITE HAEMORRHAGE 7 0.0001
599 UNINTENTIONAL MEDICAL DEVICE REMOVAL 1 0.0001
600 HYPOTENSION 17 0.0001
601 HEPATITIS C 1 0.0001
602 SCHIZOPHRENIA 1 0.0001
603 NEURALGIA 2 0.0001
604 RESPIRATORY DEPRESSION 1 0.0001
605 GLOMERULAR FILTRATION RATE DECREASED 1 0.0001
606 SPINAL OPERATION 1 0.0001
607 ABASIA 2 0.0001
608 GENERALISED OEDEMA 1 0.0001
609 ILEUS 1 0.0001
610 EXPOSURE DURING PREGNANCY 5 0.0001
611 HAIR COLOUR CHANGES 1 0.0001
612 SECRETION DISCHARGE 1 0.0001
613 DYSARTHRIA 3 0.0001
614 HAEMATEMESIS 2 0.0001
615 HYPOPHAGIA 2 0.0001
616 NO ADVERSE EVENT 14 0.0001
617 AMNESIA 5 0.0001
618 INCORRECT PRODUCT STORAGE 1 0.0001
619 BEDRIDDEN 1 0.0001
620 DEPRESSED LEVEL OF CONSCIOUSNESS 3 0.0001
621 INJECTION SITE BRUISING 6 0.0001
622 HEADACHE 47 0.0001
623 FEAR 2 0.0001
624 GINGIVAL BLEEDING 1 0.0001
625 HAEMATOCHEZIA 4 0.0001
626 MENTAL STATUS CHANGES 2 0.0001
627 ORAL DISCOMFORT 1 0.0001
628 COORDINATION ABNORMAL 1 0.0001
629 DEVICE OCCLUSION 1 0.0001
630 DISSEMINATED INTRAVASCULAR COAGULATION 1 0.0001
631 SEASONAL ALLERGY 1 0.0001
632 RED BLOOD CELL COUNT DECREASED 2 0.0001
633 BALANCE DISORDER 6 0.0001
634 SEIZURE 8 0.0001
635 PULMONARY ARTERIAL HYPERTENSION 1 0.0001
636 HYPOKINESIA 1 0.0001
637 COMPLICATION ASSOCIATED WITH DEVICE 1 0.0001
638 MUSCULOSKELETAL STIFFNESS 6 0.0001
639 PAIN 42 0.0001
640 TACHYCARDIA 6 0.0001
641 DEHYDRATION 9 0.0001
642 PULMONARY MASS 1 0.0001
643 PULMONARY OEDEMA 3 0.0001
644 HAEMORRHAGE INTRACRANIAL 1 0.0001
645 FEELING ABNORMAL 16 0.0001
646 LACRIMATION INCREASED 2 0.0001
647 OSTEOPENIA 1 0.0001
648 DISCOMFORT 4 0.0001
649 DRUG DISPENSING ERROR 1 0.0001
650 TINNITUS 3 0.0001
651 THYROID DISORDER 1 0.0001
652 MUSCULOSKELETAL CHEST PAIN 1 0.0001
653 TENDONITIS 1 0.0001
654 LUNG INFECTION 1 0.0001
655 VOMITING 30 0.0001
656 OBESITY 1 0.0001
657 ABSCESS 1 0.0001
658 CONTUSION 6 0.0001
659 MOVEMENT DISORDER 2 0.0001
660 ASTHMA 7 0.0001
661 RHINORRHOEA 4 0.0001
662 LUNG DISORDER 3 0.0001
663 CHOLELITHIASIS 2 0.0001
664 GENERALISED TONIC-CLONIC SEIZURE 1 0.0001
665 INFUSION RELATED REACTION 4 0.0001
666 VIRAL INFECTION 2 0.0001
667 SKIN DISORDER 2 0.0001
668 ANXIETY 17 0.0001
669 TYPE 2 DIABETES MELLITUS 2 0.0001
670 MALAISE 26 0.0001
671 TRANSIENT ISCHAEMIC ATTACK 2 0.0001
672 PRODUCT QUALITY ISSUE 8 0.0001
673 ACCIDENTAL EXPOSURE TO PRODUCT 6 0.0001
674 MUSCULOSKELETAL DISCOMFORT 1 0.0001
675 GAIT DISTURBANCE 11 0.0001
676 ORTHOSTATIC HYPOTENSION 1 0.0001
677 ECZEMA 3 0.0001
678 MUSCULOSKELETAL PAIN 3 0.0001
679 AMENORRHOEA 1 0.0001
680 ACUTE RESPIRATORY DISTRESS SYNDROME 1 0.0001
681 HEAD DISCOMFORT 1 0.0001
682 ISCHAEMIC STROKE 1 0.0001
683 CEREBRAL HAEMORRHAGE 2 0.0001
684 SYNOVITIS 1 0.0001
685 OSTEOMYELITIS 1 0.0001
686 CRYING 2 0.0001
687 RESTLESSNESS 2 0.0001
688 DYSURIA 2 0.0001
689 AGRANULOCYTOSIS 1 0.0001
690 NECK PAIN 3 0.0001
691 OXYGEN SATURATION DECREASED 3 0.0001
692 EYE PAIN 3 0.0001
693 RENAL FAILURE 7 0.0001
694 MUSCULOSKELETAL DISORDER 1 0.0001
695 SLEEP APNOEA SYNDROME 1 0.0001
696 EYE IRRITATION 3 0.0001
697 DRUG PRESCRIBING ERROR 1 0.0001
698 HERNIA 1 0.0001
699 ERUCTATION 1 0.0001
700 EAR PAIN 1 0.0001
701 VISION BLURRED 7 0.0001
702 SINUS DISORDER 1 0.0001
703 BLOOD PRESSURE ABNORMAL 1 0.0001
704 PREGNANCY 1 0.0000
705 SPINAL FRACTURE 1 0.0000
706 VERTIGO 3 0.0000
707 BLINDNESS 2 0.0000
708 HAEMOGLOBIN DECREASED 5 0.0000
709 INFLUENZA LIKE ILLNESS 4 0.0000
710 TOOTH LOSS 1 0.0000
711 ARTHRALGIA 20 0.0000
712 PULMONARY HYPERTENSION 1 0.0000
713 DERMATITIS 1 0.0000
714 BACK PAIN 11 0.0000
715 ANAEMIA 9 0.0000
716 OSTEOARTHRITIS 2 0.0000
717 MYALGIA 8 0.0000
718 EATING DISORDER 1 0.0000
719 IMPAIRED WORK ABILITY 1 0.0000
720 IRRITABLE BOWEL SYNDROME 1 0.0000
721 LIVER FUNCTION TEST INCREASED 1 0.0000
722 DEEP VEIN THROMBOSIS 3 0.0000
723 PERIPHERAL SWELLING 7 0.0000
724 GAMMA-GLUTAMYLTRANSFERASE INCREASED 1 0.0000
725 SEPSIS 5 0.0000
726 GLOSSODYNIA 1 0.0000
727 THERAPY NON-RESPONDER 2 0.0000
728 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 9 0.0000
729 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 8 0.0000
730 MUSCLE SPASMS 8 0.0000
731 SHOCK 1 0.0000
732 HYPOKALAEMIA 2 0.0000
733 CONFUSIONAL STATE 7 0.0000
734 INJURY 3 0.0000
735 FATIGUE 33 0.0000
736 PRODUCT PRESCRIBING ERROR 1 0.0000
737 PRODUCTIVE COUGH 2 0.0000
738 MOBILITY DECREASED 3 0.0000
739 BLOOD GLUCOSE DECREASED 2 0.0000
740 INFECTION 6 0.0000
741 JOINT SWELLING 5 0.0000
742 HYPOGLYCAEMIA 2 0.0000
743 RESPIRATORY FAILURE 3 0.0000
744 FIBROMYALGIA 1 0.0000
745 UNDERDOSE 3 0.0000
746 AGITATION 3 0.0000
747 ENCEPHALOPATHY 1 0.0000
748 ACNE 3 0.0000
749 ABDOMINAL PAIN LOWER 1 0.0000
750 CHRONIC KIDNEY DISEASE 3 0.0000
751 FALL 13 0.0000
752 SINUSITIS 4 0.0000
753 DIPLOPIA 1 0.0000
754 RESPIRATORY TRACT INFECTION 1 0.0000
755 DEAFNESS 1 0.0000
756 JOINT STIFFNESS 1 0.0000
757 ANHEDONIA 1 0.0000
758 GASTRITIS 1 0.0000
759 CARDIAC FAILURE CONGESTIVE 3 0.0000
760 PAIN OF SKIN 1 0.0000
761 DISTURBANCE IN ATTENTION 2 0.0000
762 BLOOD BILIRUBIN INCREASED 1 0.0000
763 FREQUENT BOWEL MOVEMENTS 1 0.0000
764 OEDEMA 2 0.0000
765 LIMB INJURY 1 0.0000
766 TREATMENT NONCOMPLIANCE 2 0.0000
767 HAEMOPTYSIS 1 0.0000
768 DEMENTIA 1 0.0000
769 WOUND 1 0.0000
770 PRODUCT DOSE OMISSION IN ERROR 1 0.0000
771 PAIN IN JAW 1 0.0000
772 ANGINA PECTORIS 1 0.0000
773 BLOOD CREATINE PHOSPHOKINASE INCREASED 1 0.0000
774 ABDOMINAL PAIN 8 0.0000
775 LIVER FUNCTION TEST ABNORMAL 1 0.0000
776 BONE PAIN 2 0.0000
777 ASCITES 1 0.0000
778 PSYCHOTIC DISORDER 1 0.0000
779 INSOMNIA 9 0.0000
780 RENAL INJURY 1 0.0000
781 BLOOD POTASSIUM DECREASED 1 0.0000
782 HEPATIC FAILURE 1 0.0000
783 APHASIA 1 0.0000
784 CONTRAINDICATED PRODUCT ADMINISTERED 1 0.0000
785 PLEURAL EFFUSION 2 0.0000
786 EPILEPSY 1 0.0000
787 DRUG ADMINISTRATION ERROR 1 0.0000
788 ALANINE AMINOTRANSFERASE INCREASED 2 0.0000
789 ADVERSE EVENT 3 0.0000
790 HOSPITALISATION 5 0.0000
791 NERVOUS SYSTEM DISORDER 1 0.0000
792 PRODUCT USE ISSUE 6 0.0000
793 CYSTITIS 1 0.0000
794 HIP FRACTURE 1 0.0000
795 PRODUCT DOSE OMISSION 2 0.0000
796 BLOOD CREATININE INCREASED 2 0.0000
797 IMPAIRED HEALING 1 0.0000
798 EYE DISORDER 1 0.0000
799 DECREASED APPETITE 7 0.0000
800 FUNGAL INFECTION 1 0.0000
801 URINARY RETENTION 1 0.0000
802 ABDOMINAL DISCOMFORT 5 0.0000
803 HAEMATURIA 1 0.0000
804 MULTIPLE SCLEROSIS RELAPSE 2 0.0000
805 MEMORY IMPAIRMENT 4 0.0000
806 DELIRIUM 1 0.0000
807 HYPERKALAEMIA 1 0.0000
808 HYPOXIA 1 0.0000
809 SKIN BURNING SENSATION 2 0.0000
810 WHITE BLOOD CELL COUNT DECREASED 3 0.0000
811 WRONG TECHNIQUE IN DRUG USAGE PROCESS 1 0.0000
812 NASOPHARYNGITIS 5 0.0000
813 BRONCHITIS 2 0.0000
814 THROMBOCYTOPENIA 3 0.0000
815 HEPATIC FUNCTION ABNORMAL 1 0.0000
816 DYSPNOEA EXERTIONAL 1 0.0000
817 HALLUCINATION 2 0.0000
818 ABNORMAL BEHAVIOUR 1 0.0000
819 DISORIENTATION 1 0.0000
820 CARDIAC FAILURE 2 0.0000
821 ABDOMINAL PAIN UPPER 5 0.0000
822 ROAD TRAFFIC ACCIDENT 1 0.0000
823 RENAL FAILURE ACUTE 1 0.0000
824 URINARY TRACT INFECTION 4 0.0000
825 HYPOACUSIS 1 0.0000
826 SEPTIC SHOCK 1 0.0000
827 DRY SKIN 3 0.0000
828 GASTROINTESTINAL DISORDER 2 0.0000
829 DIARRHOEA 14 0.0000
830 PNEUMONIA 7 0.0000
831 BLOOD CHOLESTEROL INCREASED 1 0.0000
832 COGNITIVE DISORDER 1 0.0000
833 NEUROPATHY PERIPHERAL 2 0.0000
834 MIGRAINE 2 0.0000
835 ATRIAL FIBRILLATION 2 0.0000
836 DYSPEPSIA 2 0.0000
837 FLUID RETENTION 1 0.0000
838 ACUTE KIDNEY INJURY 3 0.0000
839 ILLNESS 2 0.0000
840 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1 0.0000
841 NERVOUSNESS 1 0.0000
842 PLATELET COUNT DECREASED 2 0.0000
843 DRUG EFFECT DECREASED 1 0.0000
844 ARTHROPATHY 1 0.0000
845 INFLUENZA 2 0.0000
846 PANCYTOPENIA 1 0.0000
847 HYPONATRAEMIA 1 0.0000
848 FLATULENCE 1 0.0000
849 RHEUMATOID ARTHRITIS 2 0.0000
850 HERPES ZOSTER 1 0.0000
851 GENERAL PHYSICAL HEALTH DETERIORATION 2 0.0000
852 IRRITABILITY 1 0.0000
853 EMOTIONAL DISTRESS 2 0.0000
854 SUICIDE ATTEMPT 1 0.0000
855 STOMATITIS 1 0.0000
856 BLOOD GLUCOSE INCREASED 3 0.0000
857 DEVICE EXPULSION 1 0.0000
858 PSORIASIS 2 0.0000
859 FEBRILE NEUTROPENIA 1 0.0000
860 HEPATIC ENZYME INCREASED 1 0.0000
861 WEIGHT DECREASED 4 0.0000
862 SLEEP DISORDER 1 0.0000
863 HYPERTENSION 3 0.0000
864 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 1 0.0000
865 HOT FLUSH 1 0.0000
866 UNEVALUABLE EVENT 1 0.0000
867 DEPRESSION 3 0.0000
868 CONDITION AGGRAVATED 4 0.0000
869 GASTROOESOPHAGEAL REFLUX DISEASE 1 0.0000
870 DRY MOUTH 1 0.0000
871 CARDIAC ARREST 1 0.0000
872 DRUG ABUSE 1 0.0000
873 RENAL IMPAIRMENT 1 0.0000
874 SKIN EXFOLIATION 1 0.0000
875 INTENTIONAL PRODUCT USE ISSUE 1 0.0000
876 DRUG WITHDRAWAL SYNDROME 1 0.0000
877 MATERNAL EXPOSURE DURING PREGNANCY 1 0.0000
878 DEVICE ISSUE 1 0.0000
879 ADVERSE DRUG REACTION 1 0.0000
880 SUICIDAL IDEATION 1 0.0000
881 PULMONARY EMBOLISM 1 0.0000
882 MALIGNANT NEOPLASM PROGRESSION 1 0.0000
883 DEATH 8 0.0000
884 VISUAL IMPAIRMENT 1 0.0000
885 DRUG INEFFECTIVE 10 0.0000
886 NEUTROPENIA 1 0.0000
887 DRUG DEPENDENCE 1 0.0000
888 TOXICITY TO VARIOUS AGENTS 1 0.0000
889 CEREBROVASCULAR ACCIDENT 1 0.0000
890 MYOCARDIAL INFARCTION 1 0.0000
891 ALOPECIA 1 0.0000
892 SOMNOLENCE 1 0.0000
893 CONSTIPATION 1 0.0000
894 OFF LABEL USE 4 0.0000